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ABSTRACT 
 
Background and aims:The present study was envisaged to compare the efficacy of Adjunctive use of Azithromycin 
and Ciprofloxacin with Scaling and Root Planning and Scaling & Root Planning alone in the treatment of Chronic 
Periodontitis. Materials and methods: Forty five subjects with chronic periodontitis were randomly selected and 
divided into three groups as follows. Group 1: scaling and root planning without any systemic antibiotics (SRP 
alone). Group 2: scaling and root planning with systematic administration of  ciprofloxacin  (SRP+CIPRO). Group 
3: scaling and root planning alone with systemic administration of azithromycin (SRP+AZM). Periodontal 
parameters comprising of plaque index, bleeding index, probing pocket depth, clinical attachment level and 
microbiological parameters comprising of spirochete count and BANA test scores were assessed at base line and six 
weeks after completion of periodontal therapy for subjects in all the three groups. Results: The reduction in post-
treatment scores as compared to pre-treatment scores of plaque index, bleeding index, pocket depth, clinical 
attachment levels and spirochete count was highly significant in all the groups (p<0.01). BANA hydrolysis is a 
reliable marker of periodontal disease as it has proved to be a suitable test for detection of spirochetes. Conclusion: 
The judicious use of systemic antibiotics in the treatment of chronic periodontitis may provide an additional benefit 
in the clinical outcome compared to SRP alone.  
 
Keywords: Chronic periodontitis, BANA hydrolysis test, Ciprofloxacin and Azithromycin, scaling and root planing.
Introduction 
 
 
Periodontal disease is among the infectious disease 
caused by micro-organisms that colonize the tooth 
surfaces at or below the gingival margins which lead to 
the destruction of the periodontal ligament and alveolar 
bone that surrounds the teeth thus causing loss of 
attachment to the tooth. Analysis of these periodontal 
pathogens is becoming an important aspect of 
diagnosis and treatment of periodontal diseases [1]. 
Periodontal diseases, now recognized as bacterial 
infections, elicited by a complex of bacterial species, 
that interact with the host tissue cells, and release an 
array of cytokines, chemokines and mediators leading 
to the destruction[1,2].  
_______________________________ 
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Diagnostic tools are based upon enzymes diagnostic 
markers in order to identify specific periodontopathic 
bacteria, so as to enforce preventive and therapeutic 
measures toward disease control[1].The most 
comprehensive of these early studies implicated 
Porphyromonas gingivalis and spirochetes as the 
species and bacterial types that could be statistically 
associated with periodontal disease. Grossi investigated 
attachment and alveolar bone loss including the 
presence of subgingival P. gingivalis and T. forsythia. 
Socransky and Haffajee found the BANA positive 
species T. denticola, P. gingivalis, and T. forsythia 
have the highest prevalence. The Albandar used DNA 
probes to assess the relationship between the plaque 
flora and EOP and found that there was no relationship 
between A. actinomycetemcomitans and disease 
progression, but the BANA species, P. gingivalis and 
T. denticola were significantly associated with loss of 
attachment[3]. BANA-Enzymatic test™ kit is a rapid 
and reliable chair side diagnostic test, which can be 
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performed in about 15 min time, that can give 
information about the presence of three of the putative 
pathogens in subgingival plaque samples, that is,  
Porphyromonas gingivalis, Treponema denticola and 
Tannerella forsythia, shares unique ability of 
hydrolyzing the trypsin substrate. Loesche et al. studied 
a strong relationship between a BANA positive 
reaction and high levels of plaque spirochetes 
[1].Mechanical debridement is a highly demanding 
procedure with some limitations, such as the inability 
to access deep pockets, surface irregularities and 
furcation areas. Because of the infectious nature of 
periodontitis, the rationale for using adjunctive 
antimicrobial agents is to eradicate or reduce the 
numbers of pathogenic bacteria in deep pocket, root 
furcations and concavities or those residing at or within 
the periodontal tissues at the biofilm gingival interface. 
Adjunctive antimicrobial agents can be delivered either 
systemically or locally. Systemically delivery has the 
potential advantage of reaching pathogens widely 
distributed in the oral cavity as compared to local 
delivery.  Herrera stated that in specific situations such 
as patients with deep pockets or with progressive 
‘active’ disease or with specific profiles, use of 
adjunctive systemic antimicrobial could be clinically 
relevant[4].Hence, this study was aimed to compare the 
efficacy of adjunctive use of azithromycin with scaling 
and root planning (SRP), the adjunctive use of 
ciprofloxacin and SRP, and SRP alone in the treatment 
of chronic periodontitis with the help of  BANA-
Enzymatic test and by the microbiological 
examination. 
 
Materials and Methods 
 Fourty five (45) patients with in age range of 25-55 
years of both the sex will be selected from the Out 
Patient Department of Periodontology and 
Implantology, D J College of Dental Science And 
Research, Modinagar, after the approval of the ethical 
committee of the DJ College Of Dental Science And 
Research, Modinagar, Utter Pradesh. Each patient was 
given a detailed verbal and written description of the 
study. They were required to sign an informed consent 
for to commencement of the study. Patients had to 
fulfil the following inclusion criteria:- age group of 25-
55 years having at least 24 natural teeth, free from 
relevant allergies and systemic diseases, who have not 
received any surgical/non-surgical periodontal therapy 
or any antibiotic therapy for past 6 months, and chronic 
generalized periodontitis with a probing depth >5mm 
will be present. Patients who are excluded with a 
known or suspected allergy to the ciprofloxacin and 
azithromycin, aggressive periodontitis, using tobacco 
in any form, having habit of alcoholism and 
Immunocompromised patients. 
45 subjects were selected on basis of inclusion criteria 
were categorized into three treatment groups. After 
subject selection 15 patients were randomly assigned to 
one of the three groups based on the treatment method. 
Group 1 (SRP alone) n =15, scaling and root 
planning without any systemic antibiotics. 
Group 2 (SRP+CIPRO) n=15, scaling and root 
planning with systematic administration of 
ciprofloxacin 500mg, BID for 8 days. 
Group 3 (SRP+AZM) n=15, scaling and root 
planning alone with systemic administration of 
azithromycin  500mg, OD for 3 days. 
Clinical Assessments: The following clinical 
parameters were recorded for subjects in all the three 
groups:-  Plaque index, Bleeding Index, Probing pocket 
depth, Clinical attachment level. 
Clinical procedure:- On the first visit, detailed case 
history including clinical parameters [plaque index, 
gingival bleeding  index, probing pocket depth, clinical 
attachment level (with the help of UNC-15 probe to the 
nearest millimeter)], and subgingival plaque sample 
were taken. This was followed by a comprehensive 
phase I therapy which included patient education and 
motivation, plaque control, scaling and root planning. 
Complete phase 1 therapies were performed and in the 
test groups, sites were treated with SRP, followed by 
medication of ciprofloxacin and azithromycin, whereas 
in the control group, sites were treated with SRP alone. 
The patients were recalled after 6 weeks and these 
measurements (GBI, PD, PI, CAL) and sub gingival 
plaque sample were repeated. 
Microbiological examination sample collection  
Sub gingival plaque was collected from 4-6 most 
diseased tooth sites using a sterile curette. Thereafter, 
the curette tip was vigorously agitated in a test tube 
containing 0.5 ml of Sorensen buffer solution at pH of 
7.2, and placed for 20 s in a vortex mixer to get a 
homogenous plaque suspension and stored at -200C till 
dark field microscopic examination. Sub gingival 
plaque sample was taken at baseline and after 6 weeks 
in all 3 groups for microbiological examination. 
Dark field microscopic examination 
A 10 µL of plaque suspension was placed on to a glass 
slide and examined less than 10 x magnification of 
dark field microscope for evaluation of spirochetes. 
When viewed under dark field microscope, spirochetes 
are elongated motile, flexible bacteria twisted spirally 
along the long axis and seen as a shiny spiral structure 
with dark background. 
Enzyme assay (BANA hydrolysis test):- specimen 
collection and preparation 
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Remove a BANA test strip from the bottle. Record 
the patient’s name and date in the spaces on the BANA 
test strip. 
Remove subgingival plaque for sampling. Use a 
curette to obtain subgingival plaque from the apical 
third of any deep pocket.  
Each sample was applied on the reagent matrix 
affixed to the lower portion of the strip in a location 
corresponding to the number of the tooth where the 
specimen was taken. Apply the specimen to the lower 
test pad on a BANA Test strip.Before taking another 
specimen, wiping the curette on a clean cotton gauze 
pad to prevent carry-over of plaque. 
After all desired sites have been sampled and 
transferred, moisten the upper pad of the test strip with 
distilled water on a cotton swab. The pad should be just 
moist, not wet. Too much water can dilute the blue 
colour over a larger area, possibly making it too faint to 
see, and being interpreted as a false negative result. 
The reagent strip was folded at the crease mark so 
that the upper and lower matrices meet. 
The reagent strip was then placed into one of the two 
top slots of the BANA-Zyme  processor and heated for 
15 min at 55°C ± 5°C.  
The processor cycle begins when the indicator light 
comes on. Incubation is complete when the bell 
sounds. 
The lower portion of the test strips was separated 
from the upper strip and discarded. 
Evaluate the BANA Test results by comparing the 
upper, salmon-colored reagent pad with the sample 
chart on the BANA Test bottle label. Subgingival 
plaque sample was taken at baseline and after 6 weeks 
for all 3 groups. Record the results for each plaque 
sample as either negative, weakly positive or positive. 
The result of the test in each subject was noted and 
recorded. 
BANA test Scoring 5,6 
•Negative - 0 
•Weak Positive – 1 
•Positive- 2 
 The result of the test in each subject was noted and 
recorded.  
 
Statistical Analysis  
The results of the study were subjected to statistical 
analysis by ANOVA and Pearsons correlation 
coefficient. 
 
Results  
Plaque index, bleeding index, probing pocket depth and 
clinical attachment levels were assessed at base line 
and 6 weeks after the completion of periodontal 
therapy for all the subjects. Table 7-12 describes the 
intergroup comparison of change in probing depth, 
CAL, plaque index, gingival bleeding index between 
the three groups at 6 week intervals from the baseline. 
At 6 weeks interval there was a reduction in the 
probing depth, CAL, plaque index, gingival bleeding 
index in all the three groups i.e Group I, II and III 
respectively and the intergroup difference between the 
three groups was statistically significant when analyzed 
using One Way ANOVA. When the post Hoc LSD 
analysis was done it was found that reduction in the 
probing depth, CAL, plaque index, gingival bleeding 
index scores at 6 weeks interval was statistically 
significant between Group I and Group II, Group I and 
Group III,  however the difference between the Group 
II and Group III was statistically non-significant. The 
intra-group comparison between the two time intervals 
i.e baseline and 6 weeks was statistically significant for 
Group I, Group II and Group III. Table 1-6 shows 
Intragroup comparison of Group I (Scaling and Root-
planning) between the different intervals shows that 
there is significant reduction in mean scores of Probing 
depth, CAL, plaque index, gingival bleeding index at 
baseline, 6 week.  Intra group comparison of Group II 
(Scaling and Root-Planning + Ciprofloxacin) between 
the different intervals shows that there is significant 
reduction in mean scores of Probing depth, CAL, 
plaque index, gingival bleeding index at baseline, 6 
week.  Intra group comparison of Group III (Scaling 
and Root-Planning + Azithromycin) between the 
different intervals shows that there is significant 
reduction in mean scores of Probing depth, CAL, 
plaque index, gingival bleeding index at baseline, 6 
week. Thus, it shows that Scaling and Root-Planning 
with Azithromycin and Ciprofloxacin is efficient in 
reducing Probing depth, CAL, plaque index, gingival 
bleeding index. 
Table 1: Intra group comparison of change in probing depth  scores between the different intervals- baseline, 
6 weeks 
 Groups Baseline 6 Week P value Significance 
Probing 
Depth 
Group I 5.13±0.32 3.76±0.46 0.001 Significant 
Group II 5.23±0.32 3.42±0.32 0.001 Significant 
Group III 5.36±0.35 3.60±0.35 0.001 Significant 
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Table 2: Intra group comparison of cal index scores between the different intervals- baseline, 6 weeks 
 Groups Baseline 6 Week P value Significance 
CAL Group I 3.05±0.59 1.75±0.57 0.001 Significant 
Group II 3.22±0.27 1.37±0.27 0.001 Significant 
Group III 3.10±0.19 1.32±0.19 0.001 Significant 
 
Table 3: Intra group comparison of plaque index scores between the different intervals- baseline, 6 weeks 
 Groups Baseline 6 Week P value Significance 
Plaque 
Index 
Group I 2.00±0.15 1.13±0.10 0.001 Significant 
Group II 2.00±0.14 0.91±0.18 0.001 Significant 
Group III 1.97±0.10 0.92±0.15 0.001 Significant 
 
Table 4: Intra group comparison of gingival bleeding index scores between the different intervals- baseline, 6 
weeks 
 Groups Baseline 6 Week P value Significance 
Gingival 
Bleeding 
Group I 87.53±5.84 22.53±5.52 0.001 Significant 
Group II 88.40±5.43 12.53±2.77 0.001 Significant 
Group III 87.33±6.81 04.87±2.29 0.001 Significant 
 
Table 5: Intra group comparison of BANA index scores between the different intervals- baseline, 6 weeks 
 Groups Baseline 6 Week P value Significance 
BANA Scores Group I 1.48±0.24 0.48±0.15 0.001 Significant 
Group II 1.58±0.05 0.28±0.04 0.001 Significant 
Group III 1.59±0.05 0.29±0.04 0.001 Significant 
Table 6: Intra group comparison of spirochete scores between the different intervals- baseline, 6 weeks 
 Groups Baseline 6 Week P value Significance 
Spirochete
Scores 
Group I 35.53±2.92 11.53±2.41 0.001 Significant 
Group II 36.80±2.67 5.26±2.71 0.001 Significant 
Group III 36.26±2.84 6.00±2.64 0.001 Significant 
Table 7: Inter group comparison of probing depth between the three groups Post hoc analysis of intergroup 
comparison 
Dependent 
Variable 
GROUP (J) GP Mean Difference (I-J) Std. Error Sig. Significance 
Probing 
Depth 
GROUP I Group II -7.95 2.031 0.001 Significant 
Group III -6.03
*
 2.031 0.005 Significant 
GROUP II Group I 7.95
*
 2.03143 0.001 Significant 
Group III 1.91 2.03143 0.351 Non-significant 
GROUPIII Group I 6.03
*
 2.03143 0.005 Significant 
Group II -1.91 2.03143 0.351 Non-significant 
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Fig. 1: Intergroup comparison of probing depth scores between three interval for group I , group II & group 
III 
 
Table 8: Inter group comparison of cal between the three groups Post hoc analysis of intergroup comparison 
Dependent Variable (I) GP (J) GP Mean Difference 
(I-J) 
Std. 
Error 
Sig. Significance 
CAL Group I Group II -13.47
*
 2.15458 0.001 Significant 
Group III -13.49
*
 2.15458 0.001 Significant 
Group II Group I 13.47
*
 2.15458 0.001 Significant 
Group III -0.023 2.15458 0.992 Non-
significant 
Group III Group I 13.49
*
 2.15458 0.001 Significant 
Group II 0.023 2.15458 0.992 Non-
significant 
*. The mean difference is significant at the 0.05 level.  
 
 
 
Fig. 2: Intergroup comparison of cal scores between three interval for group I, group II & group III 
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Table 9: Inter group comparison of plaque index between the three groups Post hoc analysis of intergroup 
comparison 
Dependent 
Variable 
(I) GP (J) GP Mean Difference 
(I-J) 
Std. 
Error 
Sig. Significance 
Plaque Index Group I Group II -10.88
*
 2.95775 0.001 Significant 
Group III -10.17
*
 2.95775 0.001 Significant 
Group II Group I 10.88
*
 2.95775 0.001 Significant 
Group III 0.712 2.95775 0.811 Non-significant 
Group III Group I 10.176
*
 2.95775 0.001 Significant 
Group II -0.712 2.95775 0.811 Non-significant 
*. The mean difference is significant at the 0.05 level.  
 
 
Fig. 3: Intergroup comparison of plaque index between scores three interval for group I, group II & group III 
Table 10: Inter group comparison of gingival bleeding   between the three groups Post Hoc Analysis of 
Intergroup Comparison 
Dependent 
Variable 
(I) GP (J) GP Mean Difference (I-J) Std. 
Error 
Sig. Significance 
Gingival Bleeding Group I Group II -11.00
*
 .01576 0.000 Significant 
Group III -20.00
*
 .01576 0.001 Significant 
Group II Group I 11.50
*
 .01576 0.001 Significant 
Group III -8.60
*
 .01576 0.001 Significant 
Group III Group I 20.20
*
 .01576 0.001 Significant 
Group II 08.60
*
 .01576 0.001 Significant 
*. The mean difference is significant at the 0.05 level. 
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Fig. 4: Intergroup comparison of gingival bleeding index scores between three interval for group I , group II 
& group III 
 
Table 11: Inter group comparison of BANA scores between the three groups 
 
Dependent 
Variable 
(I) GP (J) GP Mean Difference (I-J) Std. 
Error 
Sig. Significance 
Bana 
Scores 
Group I Group II -13.72* 1.58811 0.001 Significant 
Group III -13.370* 1.58811 0.001 Significant 
Group II Group I 13.725* 1.58811 0.001 Significant 
Group III 0.355 1.58811 0.824 Non-significant 
Group 
III 
Group I 13.37* 1.58811 0.001 Significant 
Group II -0.355 1.58811 0.824 Non-significant 
*. The mean difference is significant at the 0.05 level. 
 
 
 
Fig. 5: Intergroup comparison of BANA scores between three interval for group I, group II & group III 
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Table 12: Inter group comparison of spirochete count between the three groups Post Hoc Analysis of 
Intergroup Comparison 
 
Dependent 
Variable 
(I) GP (J) GP Mean Difference 
(I-J) 
Std. 
Error 
Sig. Significance 
Spirochete Count Group I Group II -18.295
*
 2.05623 0.001 Significant 
Group III -16.082
*
 2.05623 0.001 Significant 
Group II Group I 18.295
*
 2.05623 0.001 Significant 
Group III 2.213 2.05623 0.288 Non-significant 
Group III Group I 16.08
*
 2.05623 0.001 Significant 
Group II -2.21 2.05623 0.288 Non-significant 
 
 
 
Fig. 6: Intergroup comparison of spirochete count between three interval for group i, group ii & group iii 
 
Discussion 
 
Periodontal diseases are bacterial infections 
characterized by inflammation and destruction of 
attachment apparatus, often leading to tooth loss. 
Traditional therapy for these Periodontal diseases has 
involved elimination or suppression of subgingival 
microbial complexes by mechanical debridement such 
as scaling and root planning or surgical procedures [7]. 
Scaling and root planning can eliminate most 
periodontitis associated bacteria, but the pathogens are 
present in the subgingival area which cannot be 
eliminated [8].Therefore adjunctive antimicrobial 
chemotherapy can improve the effectiveness of 
treatment in individuals with chronic periodontitis. Red 
complex microorganism and Actinobacillus 
actinomycetemcomitans are present in subgingival area 
and are difficult to eliminate by mechanical therapy 
alone. Both pathogens possess virulence factors that 
frustrate the host response and conventional therapeutic 
efforts by invading into the soft tissue wall of the 
pocket.9 Aa can invade epithelial cells and enter the 
underlying connective tissue, whereas Pg can invade 
epithelial cells and linger inside them.8  Their tendency 
to invade soft tissue makes them difficult to eliminate 
by scaling and root planning alone.10 Efforts to detect 
these periodontal pathogens in dental plaque have 
included microscopic measures, and BANA hydrolysis 
test. P. gingivalis, T. forsythia, and T. denticola possess 
a trypsin-like enzyme that can hydrolyze the synthetic 
trypsin substrate benzoyl DL-arginine-naphthylamide 
(BANA)[11].The presence of these organisms in 
subgingival plaque can be determined by the ability of 
the plaque to hydrolyze BANA using a 5-minute chair 
side assay[12].In microbiological examination, Dark 
field microscopy can detect number of 
microorganisms[1].Treponema palladium appear as a 
brightly illuminated objects against a dark background. 
They are identified by their typical morphology, size 
and movement. The organism moves slowly along their 
longitudinal axis accompanied by bending and twisting 
in the middle [13]. Matarazzo observed significant 
advantages in clinical and microbiological parameters 
by using antibiotics.14 Identification of periodontal 
pathogens by microbial testing in a clinical setting is 
generally limited to the main putative pathogens [15]. 
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Keestra stated that, statistically no specific type of 
antibiotic was superior over another[16].Azithromycin 
and Ciprofloxacin has  been evaluated extensively as 
an adjunct in the treatment of periodontal disease and 
useful in the treatment of periodontal disease and is 
more effective against certain Gram-negative bacteria, 
especially Actinobacillus actinomycetemcomins 
(Muller et al) P.gingivalis[17,18].  Improvement tends 
to be greater when antibiotics are administered 
(Haffajee, Mascarenhas, Oteo, Smith). They found 
improvements in clinical parameters (PD reduction and 
CAL gain), and reduction of benzoyl-DL-arginine 
naphthylamine (BANA) levels[17, 19].Studies have 
shown that the adjunctive use of systemic antibiotics 
provide a better clinical outcome, particularly in terms 
of pocket depth reduction and attachment level gain 
than SRP alone. Effects of three groups were assessed 
at baseline and 6 week after non-surgical periodontal 
therapy by means of a commercial BANA hydrolysis 
kit and by Microbiological examination. The mean 
change of three group changes from baseline to 6 
week. When three groups were compared, there was 
statistical significant difference observed. Systemic 
antibiotic used in conjunction with scaling and root 
planning can offer an additional benefit over SRP  
alone in the treatment of periodontitis in term of 
clinical attachment level, pocket depth change, plaque 
index and reduced risk of additional CAL loss. The 
reduction in spirochete count and BANA scores was 
found to correlate positively with the reduction in BOP, 
pocket depths and CAL gain.Overall, the results of the 
present study indicate that the judicial use of systemic 
antibiotics in the treatment of chronic periodontitis 
patients may provide an additional benefit in the 
clinical outcomes compared to SRP alone due to 
greater reduction in spirochete count. 
Conclusion 
The Results were obtained on the basis of all clinical 
parameters. Microbiological examination comprising 
of spirochete count and BANA test scoring. The 
clinical and microbiological parameters were assessed 
in all the groups at baseline and after 6 week. A base 
line comparison of all the parameters between the three 
groups did not show any significant difference. 
Following periodontal therapy, the periodontal health 
in all the subjects improved remarkably as evidenced 
by good plaque control, maintenance of gingival 
health, significant reduction in GBI, probing pocket 
depth and gain in clinical attachment level. This was 
also accompanied by significant reductions in 
spirochete count and BANA scores in all the three 
groups. However, subjects in Group II (SRP+ AZM) 
and in Group III (SRP+CIP) showed a greater 
reduction in spirochete count, BANA score, pocket 
depth, gain in clinical attachment level gingival 
bleeding index, plaque index when compared to 
subjects in Group I (SRP alone) which was statistically 
significant. This study has shown that there is 
significantly greater reduction in spirochete count 
when antibiotics are used as adjuvants to scaling and 
root planning. Therefore, we conclude that while 
mechanical debridement is an essential component of 
periodontal therapy, judicious use of antibiotics 
provides an added advantage. BANA hydrolysis is an 
effective and reliable tool for detecting chronic 
periodontitis. Use of azithromycin and ciprofloxacin as 
adjuvant to conventional treatment for chronic 
periodontitis generally improves clinical and 
microbiological findings compared to conventional 
treatment alone. 
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